Treatment of Acute COVID-19 and COVID-19 Exposures in Children and Adolescents

Danielle Daniels; Gregory P Conners

doi:10.1097/PEC.0000000000003143

Treatment of Acute COVID-19 and COVID-19 Exposures in Children and Adolescents

Pediatr Emerg Care. 2024 Mar 1;40(3):223-230. doi: 10.1097/PEC.0000000000003143.

Authors

Danielle Daniels¹, Gregory P Conners²

Affiliations

¹ From the Assistant Professor of Pediatrics, Division of Pediatric Infectious Diseases.
² Stanley A. August Professor and Chair of Pediatrics, Executive Director, Upstate Golisano Children's Hospital, SUNY Upstate Medical University, Syracuse, NY.

PMID: 38416652
DOI: 10.1097/PEC.0000000000003143

Abstract

The landscape of acute COVID-19 therapeutics has dramatically evolved since the onset of the pandemic. The treatment of acute COVID-19 in children and adolescents requires knowledge of risk factors and clinical features to appropriately select antiviral and immunomodulatory therapies. This review article provides updated guidance for emergency physicians in the treatment of acute COVID-19 in children and adolescents.

Publication types

Review

MeSH terms

Adolescent
COVID-19*
Child
Humans
Knowledge
Pandemics
Risk Factors